Box score
CNS Pharmaceuticals, Inc.
Reported $22.5M sold in a new Form D filed May 19, 2026 (Houston, Texas).
- Biggest raise
- $22.5M filed May 19, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Houston, Texas
- Season rank
- #118 of 1,121 in the Bio & Health League; #944 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-19 | New notice | $22.5M | $22.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1729427.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Faeth Therapeutics, Inc. rookie | Bio & Health | $24.4M |
| 2 | Klinic Inc rookie | Bio & Health | $23.9M |
| 3 | TYBR Health, Inc. | Bio & Health | $14.4M |
| 4 | CoRegen, Inc. | Bio & Health | $13.5M |
| 5 | Kayak Therapeutics, Inc. | Bio & Health | $11.9M |
| 6 | OncoNano Medicine, Inc. | Bio & Health | $10.1M |